CRSP vs RLAY: stock comparison and AI forecast
Crispr Therapeutics Ag (CRSP) and Relay Therapeutics, Inc. (RLAY) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CRSP Crispr Therapeutics Ag
- Market Cap
- $4.83B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
RLAY Relay Therapeutics, Inc.
- Market Cap
- $4.02B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
- NO CURRENT FORECAST
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- CRSP is 1.2 times larger than RLAY by market capitalization ($4.83B against $4.02B).
- CRSP turns -1812.1% of its revenue into net income, against -2763.9% for RLAY.
- CRSP carries 0.55 times debt per unit of equity, against 0.09 times for RLAY.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CRSP | RLAY |
|---|---|---|
| Market Cap | $4.83B | $4.02B |
| P/B Ratio | 2.93x | 4.52x |
| EPS | $-4.69 | $-1.61 |
| Book Value/Share | $17.04 | $4.06 |
| Revenue/Share | $0.26 | $0.05 |
| FCF/Share | $-3.90 | – |
Profitability & Margins
| Metric | CRSP | RLAY |
|---|---|---|
| ROE | -27.7% | -32.1% |
| ROA | -17.8% | -29.6% |
| ROIC | -22.0% | -33.9% |
| Operating Margin | -2114.8% | -2999.7% |
| Net Margin | -1812.1% | -2763.9% |
| EBT Margin | -1802.2% | -2999.7% |
| Tax Rate | -0.6% | – |
Financial Health
| Metric | CRSP | RLAY |
|---|---|---|
| Current Ratio | 16.21x | 18.27x |
| D/E Ratio | 0.55x | 0.09x |
| Financial Leverage | 1.55x | 1.09x |
| Interest Coverage | -39.0x | – |
| Working Capital | $2.14B | $877M |
Cash Flow
| Metric | CRSP | RLAY |
|---|---|---|
| Operating Cash Flow | -$375M | -$212M |
| Free Cash Flow | -$377M | – |
| Capital Spending | -$2M | – |
| FCF/Sales | -1496.6% | – |
| CapEx/Sales | 8.3% | – |
Operational Efficiency
| Metric | CRSP | RLAY |
|---|---|---|
| Asset Turnover | 0.01x | 0.01x |
| Fixed Assets Turnover | 0.2x | 12.0x |
Income Statement
| Metric | CRSP | RLAY |
|---|---|---|
| Total Revenue | $25M | $10M |
| Operating Income | -$532M | -$310M |
| Net Income | -$456M | -$286M |
| R&D Expense | $291M | $271M |
Dividend & Shareholder Information
| Metric | CRSP | RLAY |
|---|---|---|
| Shares Outstanding | 97M | 219M |
CRSP vs RLAY: stock comparison and AI forecast
Which is bigger, CRSP or RLAY?
CRSP is 1.2 times larger than RLAY by market capitalization ($4.83B against $4.02B).
Which one does Intratio's AI model rank higher, CRSP or RLAY?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.